公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2018 | Battery cell modeling and online estimation of the state of charge of a lithium-ion battery | Tsai I.-H.; Yu K.-H.; Tseng A.; Yen J.-Y.; Fu T.-T.; Huang E.; JIA-YUSH YEN | Journal of the Chinese Institute of Engineers, Series A/Chung-kuo Kung Ch'eng Hsuch K'an | 4 | ||
2011 | Does one size fit all? Building a framework for medical professionalism | Ho M.-J.; Yu K.-H.; Hirsh D.; TIEN-SHANG HUANG ; PAN-CHYR YANG | Academic Medicine | 70 | 63 | |
2018 | Management of gout and hyperuricemia: Multidisciplinary consensus in Taiwan | Yu K.-H.; Chen D.-Y.; Chen J.-H.; Chen S.-Y.; Chen S.-M.; Cheng T.-T.; SONG-CHOU HSIEH ; Hsieh T.-Y.; Hsu P.-F.; Kuo C.-F.; Kuo M.-C.; Lam H.-C.; Lee I.-T.; Liang T.-H.; Lin H.-Y.; Lin S.-C.; Tsai W.-P.; Tsay G.J.; Wei J.C.-C.; Yang C.-H.; Tsai W.-C. | International Journal of Rheumatic Diseases | 105 | 79 | |
2016 | Safety and efficacy of oral febuxostat for treatment of HLA-B*5801-negative gout: a randomized, open-label, multicentre, allopurinol-controlled study | Yu K.-H.; Lai J.-H.; PING-NING HSU ; Chen D.-Y.; Chen C.-J.; Lin H.-Y. | Scandinavian Journal of Rheumatology | 34 | 29 | |
2015 | Use of HLA-B∗58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: National prospective cohort study | Ko T.-M.; Tsai C.-Y.; Chen S.-Y.; Chen K.-S.; Yu K.-H.; Chu C.-S.; Huang C.-M.; Wang C.-R.; Weng C.-T.; CHIA-LI YU ; SONG-CHOU HSIEH ; Tsai J.-C.; Lai W.-T.; Tsai W.-C.; Yin G.-D.; Ou T.-T.; Cheng K.-H.; Yen J.-H.; Liou T.-L.; Lin T.-H.; Chen D.-Y.; Hsiao P.-J.; Weng M.-Y.; Chen Y.-M.; Chen C.-H.; Liu M.-F.; Yen H.-W.; Lee J.-J.; Kuo M.-C.; Wu C.-C.; Hung S.-Y.; Luo S.-F.; Yang Y.-H.; Chuang H.-P.; Chou Y.-C.; Liao H.-T.; Wang C.-W.; Huang C.-L.; Chang C.-S.; Lee M.-T.M.; PEI-JER CHEN ; Wong C.-S.; Chen C.-H.; Wu J.-Y.; Chen Y.-T.; Shen C.-Y. | BMJ (Online) | 167 | 146 |